Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

15th International Workshop on Chronic Lymphocytic Leukaemia (iwCLL 2013) /
Overview of upcoming trials and possibility of new treatment approaches in CLL

9th - 11th Sep 2013

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 30.09.13
Views: 5066
Rating:

Prof Wierda - MD Anderson Cancer Center, Houston, Texas, USA

Prof Wierda from MD Anderson Cancer Center, Houston, Texas, USA, shares his views with ecancer on upcoming trials in CLL and how the data from these will allow for new treatment approaches.  He acknowledges the excitement balanced with the challenges in the next few years in terms of novel therapies and how these fit with traditional therapies. Prof Wierda emphasises the importance of the integration of prognostic factors into therapy to predict early outcome and allow for a more personalised approach to CLL treatment. He also comments on the important aspect of the economics of treatment in this regard.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation